Supriya Lifescience Limited
NSE:SUPRIYA.NS
648.3 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 749.56 | 852.51 | 1,657.75 | 310.72 | 15.43 | 17.31 | 27.36 |
| Short Term Investments
| 111.16 | 787.37 | 591.55 | 583.713 | 731.62 | 106.66 | 58.74 |
| Cash and Short Term Investments
| 749.56 | 1,639.88 | 2,249.3 | 894.433 | 747.05 | 123.97 | 86.1 |
| Net Receivables
| 1,116.83 | 852.13 | 1,803 | 770.44 | 738.3 | 897.96 | 558.86 |
| Inventory
| 852.49 | 1,157.7 | 923.11 | 724.8 | 494.59 | 307.31 | 316.99 |
| Other Current Assets
| 1,259.16 | 999.16 | 0.03 | 1,044.767 | -0.01 | 0.01 | 233.82 |
| Total Current Assets
| 3,978.04 | 4,648.87 | 4,975.44 | 2,664 | 1,979.93 | 1,329.25 | 1,195.77 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 4,573.01 | 3,280.6 | 2,316.74 | 1,759.16 | 1,350.07 | 1,180.51 | 1,248.84 |
| Goodwill
| 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 16.56 | 11.05 | 15.08 | 30.21 | 31.98 | 19.87 | 5 |
| Goodwill and Intangible Assets
| 16.56 | 11.06 | 15.08 | 30.21 | 31.98 | 19.87 | 5 |
| Long Term Investments
| 637.95 | 252.96 | 0.53 | 0.53 | 0.53 | -106.13 | 1.19 |
| Tax Assets
| 0.01 | 0 | 39.84 | 4.34 | 1.78 | 107.04 | -0 |
| Other Non-Current Assets
| 6.81 | 9.28 | -0.01 | 0.01 | 0.01 | -0.02 | 3.15 |
| Total Non-Current Assets
| 5,234.34 | 3,553.9 | 2,372.18 | 1,794.25 | 1,384.37 | 1,201.27 | 1,258.18 |
| Total Assets
| 9,212.38 | 8,202.77 | 7,347.62 | 4,458.24 | 3,364.3 | 2,530.52 | 2,453.95 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 595.69 | 642.28 | 489.72 | 510.22 | 493.92 | 441.28 | 417.52 |
| Short Term Debt
| 4.68 | 169.79 | 221.2 | 701.29 | 798.17 | 817.03 | 950.43 |
| Tax Payables
| -26.8 | 45.87 | 64.11 | 151.85 | 21.56 | 40.88 | 26.95 |
| Deferred Revenue
| 148.68 | 16.58 | 254.48 | 175.97 | 229.07 | 65.42 | 11.31 |
| Other Current Liabilities
| 19.89 | 129.15 | 31.59 | 72.71 | 32.72 | 25.34 | 79.52 |
| Total Current Liabilities
| 768.94 | 957.8 | 996.99 | 1,460.19 | 1,553.88 | 1,349.07 | 1,458.78 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 50.2 | 54.89 | 52.95 | 20.65 | 47.03 | 106.66 | 353.3 |
| Deferred Revenue Non-Current
| 0 | 0 | 29.31 | 207.87 | 36.84 | 4.85 | 0 |
| Deferred Tax Liabilities Non-Current
| 231.52 | 136.75 | 111.49 | 80.11 | 75.1 | 96.88 | 89.51 |
| Other Non-Current Liabilities
| 8.04 | 58.75 | 0.01 | 0.01 | 159.52 | 35.15 | 5.79 |
| Total Non-Current Liabilities
| 289.76 | 250.39 | 193.76 | 308.64 | 318.49 | 243.54 | 448.6 |
| Total Liabilities
| 1,058.7 | 1,208.19 | 1,190.75 | 1,768.83 | 1,872.37 | 1,592.61 | 1,907.38 |
| Equity: | |||||||
| Preferred Stock
| 0 | 13.41 | 0.84 | 0 | 0 | 0 | 0 |
| Common Stock
| 160.97 | 160.97 | 160.97 | 146.37 | 146.37 | 146.37 | 146.37 |
| Retained Earnings
| 6,004.49 | 4,861.62 | 4,011.34 | 2,543.05 | 1,345.56 | 791.54 | 400.2 |
| Accumulated Other Comprehensive Income/Loss
| 7,992.7 | -13.41 | -0.84 | 2.31 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| -6,004.49 | 1,972 | 1,984.57 | -2.31 | -1,491.93 | 0 | 0 |
| Total Shareholders Equity
| 8,153.67 | 6,994.59 | 6,156.88 | 2,689.42 | 1,491.93 | 937.91 | 546.57 |
| Total Equity
| 8,153.67 | 6,994.59 | 6,156.88 | 2,689.42 | 1,491.93 | 937.91 | 546.57 |
| Total Liabilities & Shareholders Equity
| 9,212.38 | 8,202.78 | 7,347.63 | 4,458.25 | 3,364.3 | 2,530.52 | 2,453.95 |